ROYAL BANK OF CANADA - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$111,000
+11.0%
30,917
+14.7%
0.00%
Q2 2023$100,000
+156.4%
26,945
+128.4%
0.00%
Q1 2023$39,000
-58.1%
11,797
-50.4%
0.00%
Q4 2022$93,000
+389.5%
23,778
+200.4%
0.00%
Q3 2022$19,000
+46.2%
7,915
+19.1%
0.00%
Q2 2022$13,000
-86.6%
6,648
-87.5%
0.00%
Q1 2022$97,000
+1840.0%
53,283
+1170.2%
0.00%
Q3 2021$5,000
-54.5%
4,195
-42.5%
0.00%
Q2 2021$11,000
-38.9%
7,297
-30.5%
0.00%
Q1 2021$18,000
-25.0%
10,500
-13.0%
0.00%
Q4 2020$24,000
+84.6%
12,065
+125.0%
0.00%
Q3 2020$13,0000.0%5,363
+16.7%
0.00%
Q2 2020$13,000
-40.9%
4,597
-39.4%
0.00%
Q1 2020$22,000
-29.0%
7,586
-3.2%
0.00%
Q4 2019$31,000
+40.9%
7,839
+56.8%
0.00%
Q3 2019$22,000
+37.5%
5,000
+25.0%
0.00%
Q2 2019$16,000
+6.7%
4,0000.0%0.00%
Q1 2019$15,000
+66.7%
4,0000.0%0.00%
Q4 2018$9,000
-69.0%
4,000
-13.6%
0.00%
Q3 2018$29,000
+52.6%
4,628
+14.7%
0.00%
Q2 2018$19,0000.0%4,035
+0.9%
0.00%
Q1 2018$19,000
+58.3%
4,000
+8.0%
0.00%
Q4 2017$12,0003,702
+185000.0%
0.00%
Q3 2017$02
-50.0%
0.00%
Q1 2017$0
-100.0%
4
-99.9%
0.00%
Q2 2016$18,000
+1700.0%
3,000
+2900.0%
0.00%
Q4 2015$1,0001000.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 8,793,321$32,447,35411.70%
Velan Capital Investment Management LP 2,726,051$10,059,1289.34%
Altium Capital Management LP 2,380,000$8,782,2006.65%
AWM Investment Company, Inc. 6,017,572$22,204,8413.01%
Caligan Partners LP 847,513$3,127,3231.76%
Perceptive Advisors 11,900,255$43,911,9411.27%
Mesirow Financial Investment Management, Inc. 51,686$190,7210.81%
OBERWEIS ASSET MANAGEMENT INC/ 1,668,700$6,157,5030.75%
TANG CAPITAL MANAGEMENT LLC 1,260,000$4,649,4000.68%
EAM Investors, LLC 883,842$3,261,3770.60%
View complete list of ADMA BIOLOGICS INC shareholders